Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05827601Unknown

Zoonotic Influenza Surveillance in Belgium

Role: collaborator

NCT05620953Completed

Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)

Role: collaborator

NCT04726358Unknown

ProCaLung: Project on Cancer of the Lung

Role: collaborator

NCT01074528Not ApplicableCompleted

Mindfulness Based Stress Reduction: Supportive Treatment for Adult Patients With Cancer and Their Partners

Role: lead

NCT01949025Not ApplicableCompleted

Prevention of Serious Adverse Events in Acute Care Hospitals by Afferent Limb and Response Method Intervention - the ALARM Intervention Study.

Role: collaborator

All 5 trials loaded